ASSESSING THE EFFICACY OF NITAZOXANIDE IN TREATMENT OF CRYPTOSPORIDIOSIS USING PCR EXAMINATION

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Parasitology

Background:

• Cryptosporidiosis, caused by Cryptosporidium, is a significant gastrointestinal illness in children, leading to persistent diarrhea, malnutrition, and increased mortality.
• Effective treatments for cryptosporidiosis are crucial, especially in vulnerable pediatric populations.

Purpose of the Study:

• To evaluate the efficacy of nitazoxanide (NTZ) in clearing Cryptosporidium oocysts in infected children.
• To compare NTZ efficacy using parasitological and PCR methods in immunocompetent and immunocompromised children.

Main Methods:

• A randomized controlled trial involving 120 children (1-12 years) infected with Cryptosporidium.
• Participants were categorized into immunocompetent (ICT) and immunocompromised (ICZ) groups, receiving either NTZ or a placebo.
• Efficacy was assessed clinically, parasitologically (microscopy), and by nested-PCR.

Main Results:

• In immunocompetent children, NTZ treatment led to significantly higher oocyst clearance rates by PCR (93.3%) and microscopy (96.7%) after 4 weeks compared to placebo (43.3% PCR, 26.7% microscopy).
• Diarrhea resolution occurred faster in immunocompetent children treated with NTZ (3-5 days) compared to immunocompromised children (21-28 days).
• PCR and microscopy confirmed substantial parasite reduction in the NTZ group across both immune statuses.

Conclusions:

• Nitazoxanide is an effective treatment for reducing Cryptosporidium oocyst shedding in children.
• The drug demonstrates faster clinical efficacy in immunocompetent children.
• Combined parasitological and PCR techniques provide a comprehensive assessment of treatment effectiveness for cryptosporidiosis.